NanoVibronix, Inc. (NAOV): Price and Financial Metrics


NanoVibronix, Inc. (NAOV): $0.64

-0.01 (-2.01%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NAOV POWR Grades


  • NAOV scores best on the Sentiment dimension, with a Sentiment rank ahead of 67.5% of US stocks.
  • NAOV's strongest trending metric is Growth; it's been moving down over the last 152 days.
  • NAOV ranks lowest in Value; there it ranks in the 2nd percentile.

NAOV Stock Summary

  • NAOV has a market capitalization of $25,291,848 -- more than approximately only 4.42% of US stocks.
  • For NAOV, its debt to operating expenses ratio is greater than that reported by merely 5.2% of US equities we're observing.
  • In terms of volatility of its share price, NAOV is more volatile than 96.79% of stocks we're observing.
  • Stocks that are quantitatively similar to NAOV, based on their financial statements, market capitalization, and price volatility, are AOUT, TORM, ADN, SNOA, and OESX.
  • Visit NAOV's SEC page to see the company's official filings. To visit the company's web site, go to www.nanovibronix.com.

NAOV Valuation Summary

  • In comparison to the median Healthcare stock, NAOV's EV/EBIT ratio is 130.03% lower, now standing at -8.8.
  • NAOV's price/earnings ratio has moved down 6 over the prior 76 months.
  • NAOV's EV/EBIT ratio has moved down 6.8 over the prior 76 months.

Below are key valuation metrics over time for NAOV.

Stock Date P/S P/B P/E EV/EBIT
NAOV 2021-08-31 100.3 15.9 -9.4 -8.8
NAOV 2021-08-30 107.6 17.1 -10.1 -9.5
NAOV 2021-08-27 113.0 17.9 -10.6 -10.0
NAOV 2021-08-26 106.8 17.0 -10.0 -9.4
NAOV 2021-08-25 112.4 17.8 -10.5 -10.0
NAOV 2021-08-24 106.5 16.9 -10.0 -9.4

NAOV Growth Metrics

    The 4 year net income to common stockholders growth rate now stands at -46.82%.
  • Its 2 year net income to common stockholders growth rate is now at 0.02%.
  • Its 4 year net cashflow from operations growth rate is now at -148.35%.
NAOV's revenue has moved up $792,000 over the prior 49 months.

The table below shows NAOV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 1.01 -4.822 -12.813
2021-06-30 0.661 -4.883 -7.06
2021-03-31 0.612 -3.45 -8.321
2020-12-31 0.623 -3.391 -4.325
2020-09-30 0.62 -3.105 -4.513
2020-06-30 0.571 -3.523 -4.406

NAOV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NAOV has a Quality Grade of D, ranking ahead of 5.54% of graded US stocks.
  • NAOV's asset turnover comes in at 0.095 -- ranking 154th of 186 Medical Equipment stocks.
  • NUWE, SIEN, and ATRS are the stocks whose asset turnover ratios are most correlated with NAOV.

The table below shows NAOV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.095 0.620 20.273
2021-03-31 0.112 0.392 13.158
2020-12-31 0.172 0.343 8.655
2020-09-30 0.300 0.261 -32.726
2020-06-30 0.316 0.193 -30.341
2020-06-30 0.316 0.193 -30.341

NAOV Stock Price Chart Interactive Chart >

Price chart for NAOV

NAOV Price/Volume Stats

Current price $0.64 52-week high $4.19
Prev. close $0.65 52-week low $0.48
Day low $0.62 Volume 130,900
Day high $0.65 Avg. volume 869,988
50-day MA $0.67 Dividend yield N/A
200-day MA $1.06 Market Cap 17.78M

NanoVibronix, Inc. (NAOV) Company Bio


NanoVibronix, Inc. operates as a medical device company. The Company focuses on non-invasive biological response-activating devices that target wound healing and pain therapy. NanoVibronix develops medical devices based on its proprietary therapeutic ultrasound technology.


NAOV Latest News Stream


Event/Time News Detail
Loading, please wait...

NAOV Latest Social Stream


Loading social stream, please wait...

View Full NAOV Social Stream

Latest NAOV News From Around the Web

Below are the latest news stories about NanoVibronix Inc that investors may wish to consider to help them evaluate NAOV as an investment opportunity.

Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Yahoo | February 14, 2022

NanoVibronix Added an Additional National Payer Network in Workers’ Compensation Market

ELMSFORD, N.Y., February 07, 2022--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a Provider Agreement with EZ Health Care. Under the terms of the agreement, NanoVibronix has been added to the EZ Workers’ Comp Network, making it easier for healthcare providers to file claims and be reimbursed when prescribing PainShield for patients being t

Yahoo | February 7, 2022

AM Best Upgrades Ratings of CNO Financial Group to A (Excellent)

AM Best, the global credit rating agency for the insurance industry, recently upgraded the financial strength rating of CNO Financial Group (NYSE: CNO) and its life and health subsidiaries from A- (Excellent) to A (Excellent). The ratings reflect CNO's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, and appropriate enterprise risk management (ERM). In conjunction with the upgrade, the credit rating outlook was revised from positive to s

Yahoo | January 31, 2022

NanoVibronix Extends Reach of UroShield and PainShield through MTSG’s International Network

ELMSFORD, N.Y., January 24, 2022--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed an International Marketing, Sales and Clinical Management Agreement with Medtech Solutions Group ("MTSG"), a leader in the commercialization of healthcare technologies.

Yahoo | January 24, 2022

NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology

ELMSFORD, N.Y., January 19, 2022--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has filed three U.S. patent applications with the U.S. Patent & Trademark Office related to its SAW technology and indwelling medical devices to protect targeted new product launches and improvements to existing medical devices.

Yahoo | January 19, 2022

Read More 'NAOV' Stories Here

NAOV Price Returns

1-mo N/A
3-mo -44.83%
6-mo -38.46%
1-year -29.51%
3-year -77.93%
5-year -89.15%
YTD -38.46%
2021 36.11%
2020 -73.19%
2019 -21.27%
2018 -22.65%
2017 -21.48%

Continue Researching NAOV

Here are a few links from around the web to help you further your research on NanoVibronix Inc's stock as an investment opportunity:

NanoVibronix Inc (NAOV) Stock Price | Nasdaq
NanoVibronix Inc (NAOV) Stock Quote, History and News - Yahoo Finance
NanoVibronix Inc (NAOV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5238 seconds.